
    
      Locally advanced esophageal squamous cell carcinoma. T2-4N0-1M0-1a,TxN1M0-1a，TxNxM1a
      （according to AJCC2002）

      Scheme:

      Eligible recurrent patients with esophageal cancer will first be stratified by nodal staging
      (N0 or N1), then randomized to 2 arms at 1:1 ratio.

      Arm Cisplatin:

      Chemoradiotherapy with cisplatin and 5-fluorouracil for 4 cycles.

      Arm Paclitaxel:

      Chemoradiotherapy with weekly paclitaxel and 5-fluorouracil for 5 weeks followed by adjuvant
      chemotherapy for 2 cycles.
    
  